These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11101088)

  • 1. Biological pathways to bladder carcinogenesis.
    Gonzalgo ML; Schoenberg MP; Rodriguez R
    Semin Urol Oncol; 2000 Nov; 18(4):256-63. PubMed ID: 11101088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental models of human bladder carcinogenesis.
    Crallan RA; Georgopoulos NT; Southgate J
    Carcinogenesis; 2006 Mar; 27(3):374-81. PubMed ID: 16287878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
    Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
    Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
    Shinohara N; Koyanagi T
    Urol Res; 2002 Oct; 30(5):273-81. PubMed ID: 12389114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
    van der Kwast TH; Bapat B
    Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
    Knowles MA
    Carcinogenesis; 2006 Mar; 27(3):361-73. PubMed ID: 16352616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental models of bladder cancer: a critical review.
    Raghavan D; Debruyne F; Herr H; Jocham D; Kakizoe T; Okajima E; Sandberg A; Tannock I
    Prog Clin Biol Res; 1986; 221():171-208. PubMed ID: 3543942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bladder carcinogenesis induced by chronic exposure to persistent low-dose ionizing radiation after Chernobyl accident.
    Romanenko A; Kakehashi A; Morimura K; Wanibuchi H; Wei M; Vozianov A; Fukushima S
    Carcinogenesis; 2009 Nov; 30(11):1821-31. PubMed ID: 19643821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of gene expression patterns in superficial and invasive human bladder cancer.
    Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
    Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic strategies in bladder cancer.
    Celis JE; Wolf H; Ostergaard M
    IUBMB Life; 1999 Jul; 48(1):19-23. PubMed ID: 10791911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer.
    Cui L; Wang Y; Shi Y; Zhang Z; Xia Y; Sun H; Wang S; Chen J; Zhang W; Lu Q; Song L; Wei Q; Zhang R; Wang X
    Proteomics; 2007 Nov; 7(22):4192-202. PubMed ID: 17994624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
    J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations associated with bladder cancer progression.
    Sánchez-Carbayo M; Cordon-Cardó C
    Semin Oncol; 2007 Apr; 34(2):75-84. PubMed ID: 17382791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching for novel therapeutics and targets: insights from clinical trials.
    Mitra AP; Cote RJ
    Urol Oncol; 2007; 25(4):341-3. PubMed ID: 17628305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.